Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01417650
Other study ID # 89342
Secondary ID
Status Active, not recruiting
Phase N/A
First received August 8, 2011
Last updated August 15, 2011
Start date January 2011
Est. completion date January 2012

Study information

Verified date June 2010
Source Mashhad University of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority Iran: Ministry of Health
Study type Interventional

Clinical Trial Summary

Temporomandibular disorder (TMD) is the major cause of nondental pain in orofacial area. Laser therapy can be considered as one of the most popular methods of pain relief in TMD patients. The special features of laser light such as coherence, monochromaticity, and collimation can result in the ability of laser light to modify cellular metabolism, increase tissue repair and reduce edema and inflammation. The effectiveness of low level laser therapy in reducing the signs and symptoms of temporomandibular joint disorders has been investigated in a few studies. But, in most of the previous studies the etiology of TMD has not been considered in patient selection. Furthermore, there are some controversies in the results of these studies. According to our data, there is no study evaluating the effects of low level laser therapy on patients having TMJ osteoarthritis.

The aim of this study is to evaluate the effectiveness of low level laser therapy in improving osteoarthritis of temporomandibular joint and also to evaluate the long term effects of laser therapy on the morphology of the joint.


Description:

Project method: This study will be implemented on 20 patients aged 35-60 years referring to Department of Prosthetic Dentistry of Mashhad Dental School. The patients are selected according to the RDC/TMD criteria to include those having temporomandibular osteoarthritis with unknown etiology. The patients will be asked to take cone beam CT of temporomandibular joint to evaluate any changes in morphology of the TMJ. The patients will be randomly assigned to two groups: Group 1 (treatment group) will receive low level laser therapy. The laser light will be applied with 890 nm diode laser (Mustang 2000+, Russia) with frequency of 1500 Hz, and dose of 2 J/cm2 per point in the joint area and painful muscles if any. In Group 2 (placebo) the low power laser will be applied with a minimal dose that is very lower than the threshold necessary for therapeutic effects. Laser therapy for both the treatment and placebo groups will be applied in the back, front, and above the mandibular condyles and inside the external auditory meatus and also on painful muscles three times a week for four weeks. Patients will be evaluated at the start of the treatment, after the 6th and 12th sessions of laser therapy and also one month after the end of the treatment. At each evaluation, the pain level in opening the mouth and masticatory muscle tenderness will be measured according to the Visual Analogue Scale (VAS). The range of lateral and protrusive mandibular movements, the difficulty in chewing food and the the presence or absence of sound joints will also be evaluated. One year after treatment, the patients will be referred for taking the second cone beam CT of the TMJ to seek any change in morphology of the joint.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 20
Est. completion date January 2012
Est. primary completion date October 2011
Accepts healthy volunteers No
Gender Both
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria:

- The patients are selected according to the RDC/TMD criteria to include those having temporomandibular osteoarthritis with unknown etiology.

Exclusion Criteria:

1. Patients with systemic problems.

2. Patients using analgesic or antidepressant drugs.

3. Patients undergoing any treatment modality for TMD disease.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Radiation:
Low level laser therapy
In this group, the 890 nm diode laser (Mustang 2000+, Russia) will be applied with frequency of 1500 Hz, and dose of 2 J/cm2 per point in the joint area and painful muscles if any.
Low level laser therapy
In this group, the low level laser will be applied with a minimal dose that is very lower than the threshold necessary for therapeutic effects.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mashhad University of Medical Sciences

Outcome

Type Measure Description Time frame Safety issue
Primary Pain relief Pain is assessed by visual analogue scale (VAS) Up to 1 month after laser theray No
Secondary TMD sounds The presence or absence of articular sounds is checked. Up to 1 month after laser therapy No
Secondary Mouth opening measurement The amount of mouth opening with and without pain is measured. Up to 1 month after laser therapy No
See also
  Status Clinical Trial Phase
Completed NCT02794922 - Effectiveness of Vitamin B in Reducing Temporomandibular Joint Disorder Pain Phase 2
Completed NCT02164630 - Optimizing Resilience In Orofacial Pain and Nociception N/A
Recruiting NCT05673642 - Effect of Myofascial Release Technique Applied to in Patients With Temporomandibular Dysfunction N/A
Recruiting NCT00870922 - Effects of Masseter Manual Therapy on Temporomandibular Dysfunction Phase 1
Completed NCT01113177 - Effect of Functional Treatment on Mandibular Asymmetric Growth N/A
Completed NCT00001955 - Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions) Phase 2
Completed NCT00001601 - Evaluation and Treatment of Oral Soft Tissue Diseases N/A
Completed NCT00001600 - Diagnosis and Evaluation of Patients Needing Third Molar (Wisdom Tooth) Extraction and Patients With Chronic Facial Pain N/A
Completed NCT01794624 - Biobehavioral Pain Management in TMD N/A